Access cutting-edge epilepsy treatment through this clinical trial at a research site in Miami. Study-provided care at no cost to qualified participants.
Access epilepsy specialists in Miami at no cost
This study follows strict safety protocols and ethical guidelines
All study-related epilepsy treatment provided free
Methylphenidate (MPH) is a stimulant, FDA-approved for the treatment of attention deficit hyperactivity disorder (ADHD). It is unknown, however, if stimulants would be of benefit for memory and thinking problems due to epilepsy. In this study, participants will be assigned randomly (i.e., by flip of a coin), to a group that takes MPH and a group that takes a placebo (sugar pill). Participants will not know the group to which they have been assigned. Tests of attention and memory will be complete
Sponsor: VA Office of Research and Development
Check if you qualify for this epilepsy clinical trial in Miami, FL
If you're searching for epilepsy treatment options in Miami, FL, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Miami research site is actively enrolling participants for this clinical trial. You'll receive care from experienced epilepsy specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.